Controversies in acute stroke treatment

AACN Advanced Critical Care

Volumn 23, Issue 2, 2012, Pages 158-172

  Brethour, Mary K ^a   Nyström, Karin V ^b,c   Broughton, Sandra ^c   Kiernan, Terri E ^d   Perez, Amy ^e   Handler, Diane ^f   Swatzell, Victoria ^g   Yang, Joanna Jiehong ^h   Starr, Michele ^c,i   Seagraves, Karen B ^e   Cudlip, Fern ^j   Biby, Sharon ^k   Tocco, Susan ^l   Owens, Pauline ^c,m   Alexandrov, Anne W ⁿ  

^a Carle Hospital Stroke Team   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c NET SMART Advanced Practice Fellowship Program   (United States)

^d MAYO CLINIC   (United States)

^e GRADY HEALTH SYSTEM   (United States)

^f Mercy Medical Center Stroke Team   (United States)

^g Virginia G Piper Cancer Center   (United States)

^h LOMA LINDA UNIVERSITY   (United States)

ⁱ INTEGRIS BAPTIST MEDICAL CENTER   (United States)

^j Eden Medical Center   (United States)

^k MOSES H CONE MEMORIAL HOSPITAL   (United States)

^l ORLANDO REGIONAL MEDICAL CENTER   (United States)

^m MIDDLEMORE HOSPITAL   (New Zealand)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

acute stroke; advanced practice nurses; head ofbed positioning; intra arterial treatment; intravenous tissue plasminogen activator (tPA)

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ARTICLE; BLOOD PRESSURE; CONTINUING EDUCATION; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING; PATHOPHYSIOLOGY; STROKE;

ACUTE DISEASE; BLOOD PRESSURE; EDUCATION, CONTINUING; HUMANS; INFUSIONS, INTRAVENOUS; NURSE PRACTITIONERS; NURSE'S ROLE; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84860784198     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e31824fe1b6     Document Type: Article

References (83)

1. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use of ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42(7): 1952-1955.
3. Fonarow GC, Smith EE, Saver JL, et al. Improving doorto-needle times in acute ischemic stroke: th e design and rationale for the American Heart Association/American Stroke Association's target: stroke initiative. Stroke. 2011;42(10):2983-2989.
4. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774
5. Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med. 2003;42:611-618. (Pubitemid 37329015)
6. Winkler DT, Fluri F, Fuhr P, et al. Thrombolysis in stroke mimics. Frequency, clinical characteristics, and outcome. Stroke. 2009;40:1522-1525.
7. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology. 2010;74:1340-1345.
8. Chen Y, Bogosavljevic V, Leys D, Jovanovic D, Beslac-Bumbasirevic L, Lucas C. Intravenous thrombolytic therapy in patients with stroke mimics: baseline characteristics and safety profile. Eur J Neurol. 2011;18:1246-1250.
9. Artto V, Putaala J, Strbian D, et al; Helsinki Stroke Thrombolysis Registry Group. Stroke mimics and intravenous thrombolysis. Ann Emerg Med. 2012;59(1):27-32.
10. Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics. A 6-year, single-center study and a pooled analysis of reported series. Stroke. 2011;42:1771-1774.
11. Brethour M, Albright KC, Alexandrov AW. Can clinical presentation provide clues to conversion disorder in code stroke patients? A descriptive analysis of clinical findings. Stroke. 2011;42(3):e240.
12. Sussman BJ, Fitch TSP, Plainfield NJ. Thrombolysis with fibrinolysis in cerebral arterial occlusion. JAMA. 1958; 167:1705-1709.
13. Meyer JS, Gilroy J, Barnhart J. Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase. In: Eiekert W, Whisnant JP, eds. Cerebral Vascular Diseases. New York: Grune & Stratton; 1965:200-213.
14. Fletcher AP, Alkjaersig N, Lewis M, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976;7: 135-142.
15. Brott TG, Haley EC Jr., Levy DE, et al. Urgent therapy for stroke, 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23: 632-640.
16. Haley EC Jr., Levy DE, Brott TG, et al. Urgent therapy for stroke, 2. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
17. Hommel M, Boissel JP, Cornu C, et al. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet. 1995;345:57.
18. Donnan GA, Hommel M, Davis SM, McNeil JJ. Streptokinase in acute ischaemic stroke. Lancet. 1995;346:56.
19. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13): 1017-1025.
20. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330-1335. (Pubitemid 32530418)
21. Higashida RT, Furlan AJ, Roberts H, et al. Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34:e109-e137.
22. Saver JL, Gornbein J, Starkman S. Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit. Stroke. 2010;41:2381-2390.
23. Hacke W, Kaste M, Bluhmki E, et al; for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359: 1317-1329.
24. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282. (Pubitemid 46138121)
25. Pirkl JJ. The demographics of aging. http://transgenerational. org/aging/demographics .htm#ixzz1fWXgG75S. Accessed November 15, 2011.
26. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set up therapeutic studies in the very old. Stroke. 2009;40:1900-1902.
27. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282 (Pubitemid 46138121)
28. Wahlgren N, Ahmed A, Eriksson N, et al; for the SITSMOST Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials; Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST). Stroke. 2008; 39:3316-3322.
29. Leyden JM, Chong W, Kleinig T, Lee A, Field JB, Jannes J. A population-based study of thrombolysis for acute stroke in South Australia. Med J Aust. 2011;194 (3): 111-115.
30. Asplund K, Glader E, Norrving B, Eriksson M; for the Riks-Stroke Collaboration. Effects of extending the time window of thrombolysis to 4.5 hours observations in the Swedish Stroke Register (Riks-Stroke). Stroke. 2011;42: 2492-2497.
31. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT findings in unknown-onset and wake up strokes. Cerebrovasc Dis. 2006;21(5/6):367-371. (Pubitemid 44617303)
32. Adams HP Jr., Leira EC, Torner JC, et al. Treating patients with "wake-up" stroke: the experience of the AbESTT-11 trial. Stroke. 2008;39(12):3277-3282.
33. Barreto AD, Martin-Schild S, Hallevi H, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke. 2009;40:827-832
34. Huisa BN, Raman R, Ernstrom K, et al. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J Stroke Cerbrovasc Dis. 2010;19(6):475-479.
35. Marsh EE III, Biller J, Adams HP Jr., et al. Circadian variation in onset of acute ischemic stroke. Arch Neurol. 1990;47:1178-1180. (Pubitemid 20380995)
36. Elliott WJ. Circadian variation in the timing of stroke onset: a meta analysis. Stroke. 1998;29:992-996. (Pubitemid 28228162)
37. Barber P, Demchuk AM, Zhang J, et al; for the APECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyper-acute stroke before thrombolytic therapy. Alberta Stroke Program Early CT score. Lancet. 2000;355: 1670-1674. (Pubitemid 30248478)
38. Smith W, Lev M, English J, et al. Significance of large ves sel occlusion causing acute ischemic stroke and TIA. Stroke. 2009;40:3834-3840.
39. Kan P, Orion D, Yashar P, Levy E. Intra-arterial thrombolysis and thrombectomy for acute ischemic stroke: technique and results. J Neurosurg Sci. 2011;55:151-160.
40. Furlan A. Intra-arterial thrombolysis in acute ischemic stroke. In: J Mohr, ed. Stroke Pathophysiology, Diagnosis and Management. 5th ed. Philadelphia, PA: Sanders; 2011:1227-1240.
41. Bhatia R, Hill M, Shobha N, et al. Low rates of acute recanalization with recombinant tissue plasminogen activator in ischemic stroke real-world experience and a call for action. Stroke. 2010;41:2254-2258.
42. Saver J. Improving reperfusion therapy for acute ischaemic stroke. J Thromb Haemost. 2011;9(suppl 1): 333-343.
43. Bruns TC, Rodriguez GJ, Patel S, et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. Am J Neuroradiol. 2008;29(10):1918-1924.
44. Riedel C. Successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011;42:1775-1777.
45. Fischer U, Arnold M, Nedeltchev K, et al. NIHSS score and arteriographic findings in acute ischemic stroke. Stroke. 2005;36:2121-2127.
46. Olavarria V, Delgado M, Hoppe A, et al. Validity of the NIHSS in predicting arterial occlusion in cerebral infarction is time-dependent. Neurology. 2011;76:62-68.
47. Ribo M, Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator. Stroke. 2006;37:1000-1004.
48. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation. 2001; 103(24):2897-2902. (Pubitemid 32578125)
49. Alexandrov AW, Brethour M, Cudlip F, et al. Post-graduate fellowship education and training for nurses: the NET SMART experience. Crit Care Nurs Clin North Am. 2009;21(4):435-449.
50. Alexandrov AW, Baca T, Albright KC, DiBiase S, Alexandrov AV; for the NET SMART Faculty and Fellows. Postgraduate academic neurovascular fellowship for advanced practice nurses and physician assistants significantly increases tPA treatment rates: results from the first graduating class of the NET SMART program. Stroke. 2011;42(3):e206.
51. Alexandrov AW, Baca T, Brewer BB, et al; for the NET SMART Faculty and Fellows. Post-graduate academic neurovascular fellowship education for APNs and PAs: impact on first-year graduates and sponsoring physicians. Stroke. 2011;43(3):e-352-e-353.
52. Perednia DA, Allen A. Telemedicine technology and clinical applications. JAMA. 1995;273:483-488.
53. Levine SR, Gorman M. "Telestroke": the application of telemedicine for stroke. Stroke. 1999;30:464-469.
54. Schwamm LH, Audebert HJ, Amarenco P, et al. Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke. 2009;40: 2635-2660.
55. Stradling DA. Telestroke: state of the science and steps for implementation. Crit Care Nurs Clin North Am. 2009;21:541-548.
56. Demaerschalk BM, Miley ML, KiernanTJ, et al; for the STARR Coinvestigators. Stroke telemedicine. Mayo Clin Proc. 2009;84(1):53-64.
57. USA Today. Is there a primary stroke center near you? http://www.usatoday.com/news/health/2008-08-10-stroke-list-N.htm. Published August 10, 2008. Accessed November 14, 2011.
58. Centers for Disease Control and Prevention. First-ever county level report on stroke hospitalizations. CDC Press Release, March 28, 2008. http://www.cdc.gov/media/pressre1/2008/r080328.htm?s-cid-mediarel-r080328. Accessed November 14, 2011.
59. Kirto n OC, Folick MA, Ivy ME, et al. Midlevel practitioner workforce analysis at a university-affiliated teaching hospital. Arch Surg. 2007;142:336-341.
60. Nasca TJ, Miller RS, Holt KD. The Budget Control Act of 2011. Public Law 112-25 of the 112th United States Congress. Title 4. The Joint Select Committee on Deficit Reduction. http://www.gpo.gov/fdsys/pkg/PLAW-112publ25/pdf/PLAW- 112pub.25. Accessed November 14, 2011.
61. Summers D, Leonard A, Wen tworth D, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke. 2009;40:2011-2944.
62. Demaerschalk BM, Kiernan T-E J; STARR Investigators. Vascular neurology nurse practitioner provision of telemedicine consultations [published online ahead of print August 2, 2010]. Int J Telemed Appl. 2010:1-5. doi:10.1155/2010/507071.
63. Demchuk AM, Burgin WS, Christou I, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke. 2001;32(10):2446.
64. Wojner-Alexandrov AW, Garami Z, Chernyshev OY, Alexandrov AV. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology. 2005;64:1354-1357. (Pubitemid 40570500)
65. Durduran T, Zhou C, Yu G , et al. Bedside monitoring of cerebral blood flow in acute stroke patients during changes in head of bed position. Stroke. 2007;38:494.
66. Hargroves D, Tallis R, Pomeroy V, Bhalla A. The influence of positioning upon cerebral oxygenation after acute stroke: a pilot study. Age Ageing. 2008;37(5):581-585.
67. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important? Stroke. 1999;30(5):917-923. (Pubitemid 29211603)
68. Bernhardt J, Dewey H, Collier J, et al. A Very Early Rehabilitation Trial (AVERT). Int J Stroke. 2006;1(3):169-171. (Pubitemid 44151512)
69. Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A Very Early Rehabilitation Trial for stroke (AVERT): Phase II safety and fea sibility. Stroke. 2008;39(2):390-396. (Pubitemid 351619461)
70. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023. (Pubitemid 46850654)
71. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol. 1996;17:573-578. (Pubitemid 26101967)
72. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A; Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Socie ty. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86-91. (Pubitemid 40054180)
73. Anderson CS, Huang Y, Wang JG, et al; for the INTERACT Investigators. Intensive blood pressure Reduction in Acute Cerebral haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-399.
74. Antihypertensive Treatment of Acute Cerebral Hemorrhage investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38(2):637-648.
75. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke. 2010;41: 2108-2129.
76. Ezzeddine MA, Suri MF, Hussein HM, Qureshi AI. Blood pressure management in patients with acute stroke: pathophysiology and treatment strategies. Neurosurg Clin N Am. 2006;17(suppl 1):41-56. (Pubitemid 47633195)
77. Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology. 2003;61(8):1047-1051. (Pubitemid 37461935)
78. Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061-2065. (Pubitemid 44309904)
79. Christiansen MC, Morris S, Vallejo-Torres L, Vincent C, Mayer SA. Neurological impairment among survivors of intracerebral haemorrhage: The FAST Trial [published online ahead of print October 2011]. Neurocrit Care. doi:10.1007/s12028-011-9632-6. Accessed November 7, 2011.
80. Mayer SA, Kurtz P, Wyman A, et al; STAT Investigators. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: The Studying the Treatment of Acute hyperTension (STAT) registry. Crit Care Med. 2011;39(10):2330-2336.
81. Geeganage C, Bath PMW. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev. 2008;(4):CD000039. doi: 10.1002/14651858. CD000039.pub2.
82. Stroke Trials. INTERACT2. The second intensive blood pressure reduction in acute cerebral haemorrhage trial. http://strokecenter.org/trials/ clinicalstudies/the-second-intensive-blood-pressure-reduction-in-acute-cerebral- haemorrhage-trial. Last updated July 31, 2011. Accessed November 7, 2011.
83. ClinicalTrials.gov. ATACH-II. Antihypertensive treatment in acute cerebral hemorrhage-II. ClinicalTrials.gov identified: NCT01176565. http://clinicaltrials.gov/ct2/show/NCT01176565?term-atach&rank-2. Last updated February 25, 2011. Accessed November 7, 2011.